In ER+/HER2− breast cancer, a subtype normally less immunogenic than TNBC and HER+ breast cancer, the prognostic role of TILs is not fully elucidated, although several studies suggest that the presence of TILs is associated with a less favorable prognosis [7]. This evidence concerns the gene ESR1 and breast carcinoma.